BRIEF-Adial Pharmaceuticals Granted End Of Phase 2 Meeting From FDA

Reuters
08 May
BRIEF-<a href="https://laohu8.com/S/ADIL">Adial Pharmaceuticals</a> Granted End Of Phase 2 Meeting From FDA

May 8 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:

  • ADIAL PHARMACEUTICALS GRANTED END OF PHASE 2 MEETING FROM THE U.S. FOOD AND DRUG ADMINISTRATION

  • ADIAL PHARMACEUTICALS INC - FDA MEETING SCHEDULED FOR JULY 25, 2025

Source text: ID:nGNX53XlvP

Further company coverage: ADIL.O

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10